361 related articles for article (PubMed ID: 25219808)
1. The genetic signatures of pediatric high-grade glioma: no longer a one-act play.
Diaz AK; Baker SJ
Semin Radiat Oncol; 2014 Oct; 24(4):240-7. PubMed ID: 25219808
[TBL] [Abstract][Full Text] [Related]
2. Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma.
Ocasio JK; Budd KM; Roach JT; Andrews JM; Baker SJ
Cancer Metastasis Rev; 2023 Jun; 42(2):367-388. PubMed ID: 37119408
[TBL] [Abstract][Full Text] [Related]
3. Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.
Haase S; Nuñez FM; Gauss JC; Thompson S; Brumley E; Lowenstein P; Castro MG
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348922
[TBL] [Abstract][Full Text] [Related]
4. Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas.
Paugh BS; Zhu X; Qu C; Endersby R; Diaz AK; Zhang J; Bax DA; Carvalho D; Reis RM; Onar-Thomas A; Broniscer A; Wetmore C; Zhang J; Jones C; Ellison DW; Baker SJ
Cancer Res; 2013 Oct; 73(20):6219-29. PubMed ID: 23970477
[TBL] [Abstract][Full Text] [Related]
5. Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
Jones C; Baker SJ
Nat Rev Cancer; 2014 Oct; 14(10):. PubMed ID: 25230881
[TBL] [Abstract][Full Text] [Related]
6. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis.
Lu VM; Alvi MA; McDonald KL; Daniels DJ
J Neurosurg Pediatr; 2018 Nov; 23(3):308-316. PubMed ID: 30544362
[TBL] [Abstract][Full Text] [Related]
7. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
[TBL] [Abstract][Full Text] [Related]
8. Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma.
Subashi E; Cordero FJ; Halvorson KG; Qi Y; Nouls JC; Becher OJ; Johnson GA
J Neurooncol; 2016 Jan; 126(2):243-51. PubMed ID: 26511492
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
10. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.
Wu G; Diaz AK; Paugh BS; Rankin SL; Ju B; Li Y; Zhu X; Qu C; Chen X; Zhang J; Easton J; Edmonson M; Ma X; Lu C; Nagahawatte P; Hedlund E; Rusch M; Pounds S; Lin T; Onar-Thomas A; Huether R; Kriwacki R; Parker M; Gupta P; Becksfort J; Wei L; Mulder HL; Boggs K; Vadodaria B; Yergeau D; Russell JC; Ochoa K; Fulton RS; Fulton LL; Jones C; Boop FA; Broniscer A; Wetmore C; Gajjar A; Ding L; Mardis ER; Wilson RK; Taylor MR; Downing JR; Ellison DW; Zhang J; Baker SJ
Nat Genet; 2014 May; 46(5):444-450. PubMed ID: 24705251
[TBL] [Abstract][Full Text] [Related]
11. Invited Review: Emerging functions of histone H3 mutations in paediatric diffuse high-grade gliomas.
Kasper LH; Baker SJ
Neuropathol Appl Neurobiol; 2020 Feb; 46(1):73-85. PubMed ID: 31859390
[TBL] [Abstract][Full Text] [Related]
12. Signal Transduction in Diffuse Intrinsic Pontine Glioma.
Duchatel RJ; Jackson ER; Alvaro F; Nixon B; Hondermarck H; Dun MD
Proteomics; 2019 Nov; 19(21-22):e1800479. PubMed ID: 31328874
[TBL] [Abstract][Full Text] [Related]
13. Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG).
Bailey CP; Figueroa M; Mohiuddin S; Zaky W; Chandra J
Bioengineering (Basel); 2018 Oct; 5(4):. PubMed ID: 30340362
[TBL] [Abstract][Full Text] [Related]
14. Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma.
Rallis KS; George AM; Wozniak AM; Bigogno CM; Chow B; Hanrahan JG; Sideris M
Cancer Genomics Proteomics; 2022; 19(4):390-414. PubMed ID: 35732328
[TBL] [Abstract][Full Text] [Related]
15. Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities.
Sun Y; Bailey CP; Sadighi Z; Zaky W; Chandra J
J Neurooncol; 2020 Oct; 150(1):17-26. PubMed ID: 32504402
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma.
Bailey CP; Figueroa M; Gangadharan A; Yang Y; Romero MM; Kennis BA; Yadavilli S; Henry V; Collier T; Monje M; Lee DA; Wang L; Nazarian J; Gopalakrishnan V; Zaky W; Becher OJ; Chandra J
Neuro Oncol; 2020 Sep; 22(9):1302-1314. PubMed ID: 32166329
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic programming of pediatric high-grade glioma: Pushing beyond proof of concept to clinical benefit.
Groves A; Cooney TM
Front Cell Dev Biol; 2022; 10():1089898. PubMed ID: 36589742
[TBL] [Abstract][Full Text] [Related]
18. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.
Barrow J; Adamowicz-Brice M; Cartmill M; MacArthur D; Lowe J; Robson K; Brundler MA; Walker DA; Coyle B; Grundy R
Neuro Oncol; 2011 Feb; 13(2):212-22. PubMed ID: 21138945
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic landscape and 3D genome structure in pediatric high-grade glioma.
Wang J; Huang TY; Hou Y; Bartom E; Lu X; Shilatifard A; Yue F; Saratsis A
Sci Adv; 2021 Jun; 7(23):. PubMed ID: 34078608
[TBL] [Abstract][Full Text] [Related]
20. Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.
Saratsis AM; Kambhampati M; Snyder K; Yadavilli S; Devaney JM; Harmon B; Hall J; Raabe EH; An P; Weingart M; Rood BR; Magge SN; MacDonald TJ; Packer RJ; Nazarian J
Acta Neuropathol; 2014; 127(6):881-95. PubMed ID: 24297113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
